Lawrence Yannuzzi is an American physician, ophthalmologist, and vitreo-retinal surgeon who is noted as an internationally recognized [1] retinal specialist.
Yannuzzi graduated from Harvard College. He graduated from the Boston University School of Medicine where he received an M.D. degree in 1964. He did a residency in ophthalmology at the Manhattan Eye, Ear and Throat Hospital from 1965 to 1968. He was board certified in ophthalmology in 1971. [2]
He is married and has two sons and a daughter, who is a psychiatrist. [3]
He is a professor of clinical ophthalmology at Columbia University College of Physicians and Surgeons, vice–chairman and director of The Retinal Research Center of the Manhattan Eye, Ear & Throat Hospital, and founder and president of The Macula Foundation. [4]
Yannuzzi has published more than 550 scientific papers and 12 textbooks, with particular concentration in diseases of the macula such as diabetic retinopathy and age-related macular degeneration. [5]
He is on the Board of Directors for Lighthouse International, a non-profit organization that does work in vision rehabilitation services, education, research, prevention and advocacy. [1]
Yannuzzi is a pioneer in angiography. [6] He and his colleagues are credited as describing and coining the term "idiopathic polypoidal choroidal vasculopathy", a particular type of hemorrhagic maculopathy. [7]
He is a recipient of a Lifetime Achievement Award from the American Academy of Ophthalmology. [4]
Yannuzzi practices in New York City.
Ophthalmology is a surgical subspecialty within medicine that deals with the diagnosis and treatment of eye disorders. An ophthalmologist is a physician who undergoes subspecialty training in medical and surgical eye care. Following a medical degree, a doctor specialising in ophthalmology must pursue additional postgraduate residency training specific to that field. This may include a one-year integrated internship that involves more general medical training in other fields such as internal medicine or general surgery. Following residency, additional specialty training may be sought in a particular aspect of eye pathology. Ophthalmologists prescribe medications to treat eye diseases, implement laser therapy, and perform surgery when needed. Ophthalmologists provide both primary and specialty eye care - medical and surgical. Most ophthalmologists participate in academic research on eye diseases at some point in their training and many include research as part of their career. Ophthalmology has always been at the forefront of medical research with a long history of advancement and innovation in eye care.
Manhattan Eye, Ear and Throat Hospital (MEETH) is a specialty hospital in New York City that was founded in 1869 and is currently located on the Upper East Side of Manhattan at 210 East 64th Street. After 131 years as an independent entity, in 2000 MEETH affiliated with Lenox Hill Hospital, a 652-bed acute care hospital, established in New York City in 1857 and located at 77th Street in Manhattan. MEETH is recognized in medical circles for its long history of contributions in developing the fields of ophthalmology, otolaryngology and plastic surgery. MEETH provides thousands of patients a year with treatment in its ambulatory surgery facilities.
Charles Louis Schepens was an influential Belgian ophthalmologist, regarded by many in the profession as "the father of modern retinal surgery", and member of the French Resistance.
Marshall Miller Parks was an American ophthalmologist known to many as "the father of pediatric ophthalmology".
Ian Jeffrey Constable is an Australian ophthalmologist and the founder and director of the Lions Eye Institute in Perth, Western Australia. He was the Foundation Lions Professor of Ophthalmology at the University of Western Australia, and the Foundation Director of UWA's Centre for Ophthalmology and Visual Science.He is now Patron of the Lions Eye Institute
New York Eye and Ear Infirmary of Mount Sinai (NYEE) is located at East 14th Street and Second Avenue in lower Manhattan, New York City. Founded on August 14, 1820, NYEE is America's first specialty hospital and one of the most prominent in the fields of ophthalmology and otolaryngology in the world, providing primary inpatient and outpatient care in those specialties. Previously affiliated with New York Medical College, as of 2013 it is affiliated with the Icahn School of Medicine at Mount Sinai as a part of the membership in the Mount Sinai Health System.
Saul Cvi Merin was an Israeli ophthalmologist specializing in the diagnosis and treatment of retinal and genetic eye diseases. His book Inherited Eye Diseases is now in its second edition.
The Illinois Eye & Ear Infirmary (IEEI) is a center of ophthalmology and otolaryngology research and clinical practice.
Paul T. Finger, MD, FACS, is an ophthalmologist in New York, New York, specializing in ocular oncology. Finger is a Clinical Professor of Ophthalmology at the New York University School of Medicine in New York City, New York. He is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital and NYU School of Medicine. He is Chair of the Ophthalmic Oncology Task Force for the American Joint Committee on Cancer (AJCC), wrote the eye cancer staging systems section for the Union International for Cancer Control (UICC). As Chair, he brought together an OOTF to develop consensus eye plaque radiation guidelines for The American Brachytherapy Society - American Association of Physicists in Medicine. Dr. Finger was the first the only ophthalmologist asked to serve on the 2012 American Association of Physicists in Medicine’s Task Group-129 that produced both dosimetry and quality assurance standards for plaque brachytherapy. As of 2021, Dr. Finger has authored over 335 peer-review scientific articles, 2 books, 54 book chapters and 2 web sites.
Arnall Patz was an American medical doctor and research professor at Johns Hopkins University. In the early 1950s, Patz discovered that oxygen therapy was the cause of an epidemic of blindness among some 10,000 premature babies. Following his discovery, there was a sixty percent reduction in childhood blindness in the United States. He also conducted pioneering research in the 1960s into the use of lasers in the treatment of retinal disorders. He received the Lasker Award in 1956 for his research into the causes and prevention of blindness and the Presidential Medal of Freedom in 2004 for his lifetime of work in the field of ophthalmology.
Elias I. Traboulsi is a physician in the fields of ophthalmic genetics and pediatric ophthalmology.
Bascom Palmer Eye Institute is the University of Miami School of Medicine's ophthalmic care, research, and education center. The institute is based in the Health District of Miami, Florida, and has been ranked consistently as the best eye hospital and vision research center in the nation.
Steve Charles is a vitreoretinal surgeon who has developed many of the techniques and devices used by vitreoretinal surgeons worldwide. He is a board certified ophthalmologist and vitreoretinal surgeon, a mechanical/electrical engineer who has 48 patents or patents applied for, and has developed many of the techniques and devices used by vitreoretinal surgeons worldwide. He has performed over 38,000 vitreoretinal surgeries, lectured in 50 countries and operated in 25, delivered 17 named lectures, and over 1000 speaking trips. He authored a leading textbook in the field which is now in the 5th edition and in 6 languages and authored over 174 articles in the medical literature and over 50 book chapters.
Julia A. Haller is an American ophthalmologist who is a Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University. She also holds the William Tasman, M.D. Endowed Chair at Wills Eye Hospital in Philadelphia, where she is Ophthalmologist-in-Chief.
Michael David Abràmoff is a Dutch-American ophthalmologist, computer scientist and entrepreneur. He is the Robert C. Watzke Professor of Ophthalmology and Visual Sciences at the Roy J. and Lucille A. Carver College of Medicine at the University of Iowa. He is the Founder and Executive Chairman of Digital Diagnostics, of Iowa City, called by Wired Magazine "the bolder AI company", and which received the first FDA marketing authorization for an autonomous diagnostic AI system in any field of medicine.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Emily Ying Chew, M.D., is an American ophthalmologist and an expert on the human retina with a strong clinical and research interest in diabetic eye disease and age-related eye diseases. She currently works for the National Eye Institute (NEI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she serves as deputy director of the Division of Epidemiology and Clinical Applications (DECA) and the Institute's deputy clinical director. She designs and implements Phase 1, 2 and 3 clinical trials at the NIH Clinical Center. Chew is board certified in ophthalmology.
Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital and an Honorary Consultant Ophthalmologist at the Great Ormond Street Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.
Gerd Uwe Auffarth is a German eye surgeon and is Chairman of the Department of Ophthalmology at the Heidelberg University Eye Hospital and Head of the David J. Apple Center for Vision Research which includes the David J. Apple International Laboratory for Ocular Pathology.
Atul Kumar is an Indian ophthalmologist who is currently the Chief & Professor of Ophthalmology at Dr. Rajendra Prasad Centre for Ophthalmic Sciences (RPC-AIIMS), the national apex ophthalmic centre at All India Institute of Medical Sciences, Delhi. He was awarded the Padma Shri award in January 2007 for his services to the medical field. He specializes in vitreoretinal surgery and also heads the Vitreo-Retinal, Uvea and ROP services at RPC-AIIMS.